• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    CareDx, Miromatrix Collaborate on Bioengineered Organs Research

    Capitainer Releases to Market its Fully Automated Sample Handler

    Titan Medical Licenses Most IP to Intuitive; CEO Steps Down

    Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies

    Concept Medical Earns 4th FDA IDE Nod for MagicTouch PTA
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Checking Up on Surgical Robotics

    Building a Network: How Synchron Is Developing a New Device—and a New Market

    Six Lessons Learned on Developing a Strong Company Culture

    As Hiring Slows, Companies Look Inward to Fulfill Talent Needs

    Artificial Intelligence: Medtech Opportunity or Health Danger?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Fusion Biotec Inc.

    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    NDH Medical Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    6 Considerations for Companies on the Cusp of Being Acquired

    3 Key Elements to Consider When Managing a Medtech Sales Force

    Tech-Enabled Virtual Speech Therapy Improves Speech & Communication Skills

    Practical Strategies for Digitization and Integration in Medtech Manufacturing

    Sensors: The Heart of Minimally Invasive Equipment Technology
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Fusion Biotec Inc.

    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    NDH Medical Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Glaucoma Study Confirms Long-term Efficacy, Safety of Glaukos iStent Implantation

    At five years postoperative, mean IOP decreased 38 percent to 14.7 mmHg and topical ocular hypotensive medication use fell 75 percent.

    Business Wire04.24.19
    Glaukos Corporation announced that results of an international glaucoma study showed use of iStent Trabecular Micro-Bypass Stent during cataract surgerydelivered a 38 percent reduction in mean intraocular pressure (IOP) to 14.7 mmHg after five years of follow-up.
     
    The prospective, non-randomized, consecutive case series was conducted at the Eye Clinic Marienplatz in Munich, Germany, by Medical Director Tobias H. Neuhann, M.D., and included 65 eyes of 43 patients with open-angle glaucoma or ocular hypertension. Thirty-eight percent of eyes had undergone prior trabeculectomy and/or glaucoma laser procedures and 68 percent were on at least two preoperative glaucoma medications.
     
    Additional study findings for eyes followed through five years (n=26 eyes) included:
    • A total of 92 percent of eyes had IOP ≤18 mmHg and 65 percent had IOP ≤15 mmHg.
    • Mean medication use declined 75 percent to 0.5 topical ocular hypotensive medications, vs. 2.0 preoperatively.
    • Approximately 69 percent of eyes were medication-free vs. 5 percent preoperatively.
    • The safety profile was favorable throughout follow-up.
     
    “The five-year outcomes for this study—which demonstrated appreciable reductions in IOP and medications along with an excellent safety profile—are among the longest of any published report on the use of trabecular micro-bypass stents in combination with cataract surgery,” said Dr. Neuhann, who performed all of the procedures and authored the study. “Importantly, the dataset evaluated outcomes in a varied patient population in terms of the type of glaucoma and the level of disease severity, and included many patients with significant preoperative medication burden and a history of prior glaucoma surgeries. This realistic scenario makes the outcomes particularly relevant for the typical ophthalmic practice, which must regularly evaluate treatment options for a wide range of glaucoma patients’ needs.”
     
    Glaukos is the pioneer of Micro-Invasive Glaucoma Surgery, or MIGS. The U.S. Food and Drug Administration (FDA) approved the company’s first MIGS device, the iStent, in 2012 and approved its second-generation iStent inject Trabecular Micro-Bypass System in 2018.
     
    Inserted through a small corneal incision made during cataract surgery, the iStent is designed to reduce IOP by restoring the natural physiological outflow of aqueous humor. The iStent inject relies on the same fluidic method of action but is designed to deploy two stents into separate trabecular meshwork locations through a single corneal entry point for enhanced IOP reduction and procedural ease. The iStent inject is also approved for use in the European Union, Armenia, Australia, Brazil, Canada, Hong Kong, Singapore, South Africa, and other international markets.
     
    “Dr. Neuhann’s five-year results further underscore the potent and sustained IOP-lowering capability of our iStent technology in real-world clinical situations,” said Thomas Burns, Glaukos president and CEO. “Moreover, these latest results add to the already formidable body of clinical evidence that helps ophthalmic surgeons appreciate the durability, predictability and reliability of using a single or multiple trabecular micro-bypass stents in combination with cataract surgery to effectively manage patients’ IOP.”
     
    Glaucoma is characterized by progressive, irreversible vision loss caused by optic nerve damage. There is no cure for the disease. However, by reducing the eye pressure, the only proven effective treatment, vision may be stabilized. Based on analysis of population-based surveys, medical claims data and other statistics, the company estimates that there are approximately 5.4 million people in the United States with primary open-angle glaucoma, the most common form of the disease.
     
    The iStent inject Trabecular Micro-Bypass System Model G2-M-IS is indicated for use in conjunction with cataract surgery for the reduction of IOP in adult patients with mild-to-moderate primary open-angle glaucoma.
     
    The iStent Trabecular Micro-Bypass Stent is indicated for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild-to-moderate open-angle glaucoma currently treated with ocular hypotensive medication.
     
    Glaukos is an ophthalmic medical technology and pharmaceutical company developing and commercializing surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. Glaukos launched the iStent, its first MIGS device, in the United States in July 2012 and launched its next-generation iStent inject device in the United States in September 2018. Glaukos is leveraging its platform technology to build a proprietary portfolio of micro-scale injectable therapies designed to address the complete range of glaucoma disease states and progression. The company believes the iStent inject, measuring 0.23 mm wide and 0.36 mm long, is the smallest medical device ever approved by the FDA.
    Related Searches
    • ul
    • physiological
    • medical technology
    • company
    Suggested For You
    A New, Tailored Review Framework for Artificial Intelligence-Based Devices A New, Tailored Review Framework for Artificial Intelligence-Based Devices
    FDA to Modernize Mammography Services and Improve Their Quality FDA to Modernize Mammography Services and Improve Their Quality
    VivaLNK Launches IoT-Enabled Medical Wearable Sensor Platform for Continuous Patient Monitoring VivaLNK Launches IoT-Enabled Medical Wearable Sensor Platform for Continuous Patient Monitoring
    FDA Warns J&J and Sientra for Breast Implant Compliance Failure FDA Warns J&J and Sientra for Breast Implant Compliance Failure
    Alcon Acquires PowerVision for $285M Alcon Acquires PowerVision for $285M
    FDA to Closely Examine Surgical Stapler Risks FDA to Closely Examine Surgical Stapler Risks
    FDA Commissioner Scott Gottlieb to Step Down FDA Commissioner Scott Gottlieb to Step Down
    Monarch Medical Technologies Appoints Expert in Pediatric Diabetes to Medical Advisory Board Monarch Medical Technologies Appoints Expert in Pediatric Diabetes to Medical Advisory Board
    ICU Medical Recalls ChemoLock Vial Spike (20mm) Due to Risk of Detached Plastic Particles ICU Medical Recalls ChemoLock Vial Spike (20mm) Due to Risk of Detached Plastic Particles
    FDA Orders Doctor to Cease Marketing Unapproved Breast Augmentation Device FDA Orders Doctor to Cease Marketing Unapproved Breast Augmentation Device
    Electrophysiology to Remain a Highly Competitive, Dynamic Market in the Future Electrophysiology to Remain a Highly Competitive, Dynamic Market in the Future
    Latest Steps to Strengthen FDA’s 510(k) Program for Premarket Review Latest Steps to Strengthen FDA’s 510(k) Program for Premarket Review
    First Patient Implanted With Implandata’s Eye Pressure Sensor for Continual Glaucoma Monitoring First Patient Implanted With Implandata’s Eye Pressure Sensor for Continual Glaucoma Monitoring
    FDA FDA's New Actions Concerning the Digital Health Pre-Cert Pilot Program
    Boston Scientific Buys Millipede for $325M Boston Scientific Buys Millipede for $325M

    Related Breaking News

    • Digital Health | Software & IT
      A New, Tailored Review Framework for Artificial Intelligence-Based Devices

      A New, Tailored Review Framework for Artificial Intelligence-Based Devices

      The FDA is exploring a framework that would allow for modifications to algorithms to be made from real-world learning and adaptation.
      Scott Gottlieb, M.D. , Commissioner, U.S. Food and Drug Administration 04.03.19

    • Diagnostics
      FDA to Modernize Mammography Services and Improve Their Quality

      FDA to Modernize Mammography Services and Improve Their Quality

      Proposed rule would require breast density reporting, enhance the FDA’s ability to enforce mammography facilities’ compliance with standards.
      U.S. Food and Drug Administration 03.27.19

    • Digital Health | Patient Monitoring
      VivaLNK Launches IoT-Enabled Medical Wearable Sensor Platform for Continuous Patient Monitoring

      VivaLNK Launches IoT-Enabled Medical Wearable Sensor Platform for Continuous Patient Monitoring

      Vitalic Medical partners with VivaLNK to detect early signs of patient health deterioration and risk of falling.
      VivaLNK 03.26.19


    • Surgical
      FDA Warns J&J and Sientra for Breast Implant Compliance Failure

      FDA Warns J&J and Sientra for Breast Implant Compliance Failure

      The two breast implant manufacturers failed to comply with post-approval study requirements.
      U.S. Food and Drug Administration 03.20.19

    • Surgical
      Alcon Acquires PowerVision for $285M

      Alcon Acquires PowerVision for $285M

      PowerVision Inc. was formed to develop fluid-based accommodating intraocular lenses for cataract surgery patients.
      GlobeNewswire 03.18.19

    Loading, Please Wait..

    Trending
    • AVS Collects An Additional $8.8 Million In Its Series B Funding Round
    • Philips Names New Supervisory Board Chairman
    • Healthcare Changes Prompt Medtronic To Merge Sales Force Medtronic, Inc. Is Combining Its U.S. Ca
    • Medtronic To Buy Wearable Insulin Patch Maker EOFlow For $738M
    • Noah Medical's Galaxy System Achieves First U.S. Robotic Bronchoscopy
    Breaking News
    • CareDx, Miromatrix Collaborate on Bioengineered Organs Research
    • Capitainer Releases to Market its Fully Automated Sample Handler
    • Titan Medical Licenses Most IP to Intuitive; CEO Steps Down
    • Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies
    • Concept Medical Earns 4th FDA IDE Nod for MagicTouch PTA
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • Computer Concepts for Medical Device Design
    • IVD Manufacturers Are Being Put to the Test
    • The New State of Medtech Outsourcing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
    BGG Receives Patent for Saw Palmetto ID Method
    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    Coatings World

    Latest Breaking News From Coatings World

    Boeing Starts Construction on New St. Louis Facility
    Brand Finance: Post-COVID Recovery Slows for Chemicals Industry Battling Energy Crisis
    BCF Calls for Greater Urgency on REACH Impasse
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CareDx, Miromatrix Collaborate on Bioengineered Organs Research
    Capitainer Releases to Market its Fully Automated Sample Handler
    Titan Medical Licenses Most IP to Intuitive; CEO Steps Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AVROBIO Sells Cystinosis Gene Therapy for $87.5 Million
    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Unilever Uses AI for Product Development
    Beautycounter Names New Interim CEO
    Shaz & Kiks Available at Sephora
    Happi

    Latest Breaking News From Happi

    Covergirl Introduces Clean Fresh Yummy Gloss Collection
    Shaz and Kiks Launches at Sephora
    Beautycounter Appoints Board Director Mindy Mackenzie Interim CEO
    Ink World

    Latest Breaking News From Ink World

    ACTEGA, Makro Labelling to Advance Signite Technology
    BCF Requests Greater Urgency on REACH Impasse
    Updated Method Published for Entire BASF Product Portfolio
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    ACTEGA teams with Makro Labelling to advance Signite technology
    Constantia Flexibles and SB Packagings commence joint venture
    Inland donates new VersaStudio printer to local high school
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Mann+Hummel Names President Air Filtration Americas
    KNH Launches Eco-Friendly Menstrual Pads
    Niine Introduces India's First PLA-Based Sanitary Pads
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Enrollment Completed in Anika Therapeutics' Hyalofast Study
    Exactech Releases Next-Gen GPS Shoulder
    Data Shows Favorable Survivorship of MISHA Knee System & Reduction of Arthroplasty Risk in Patients
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Presents Path to Accelerate Revenue Growth
    STMicroelectronics Introduces Waterproof MEMS Pressure Sensor
    Graphene Flagship to Join Euro Nano Forum 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login